[HTML][HTML] Current screening methodologies in drug discovery for selected human diseases

OM Lage, MC Ramos, R Calisto, E Almeida… - Marine drugs, 2018 - mdpi.com
The increase of many deadly diseases like infections by multidrug-resistant bacteria implies
re-inventing the wheel on drug discovery. A better comprehension of the metabolisms and …

On dihydroorotate dehydrogenases and their inhibitors and uses

H Munier-Lehmann, PO Vidalain… - Journal of medicinal …, 2013 - ACS Publications
Proper nucleosides availability is crucial for the proliferation of living entities (eukaryotic
cells, parasites, bacteria, and virus). Accordingly, the uses of inhibitors of the de novo …

[HTML][HTML] Open source drug discovery with the malaria box compound collection for neglected diseases and beyond

WC Van Voorhis, JH Adams, R Adelfio… - PLoS …, 2016 - journals.plos.org
A major cause of the paucity of new starting points for drug discovery is the lack of
interaction between academia and industry. Much of the global resource in biology is …

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

MA Phillips, J Lotharius, K Marsh, J White… - Science translational …, 2015 - science.org
Malaria is one of the most significant causes of childhood mortality, but disease control
efforts are threatened by resistance of the Plasmodium parasite to current therapies …

[图书][B] Organic electrochemistry

O Hammerich, B Speiser - 2016 - api.taylorfrancis.com
Organic electrochemistry is concerned with the reduction and oxidation of organic molecules
at electrodes. Although it is now more than 200 years ago that the so-called Volta pile was …

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with …

JM Coteron, M Marco, J Esquivias, X Deng… - Journal of medicinal …, 2011 - ACS Publications
Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the
development of resistance. In an effort to identify new potential antimalarials, we have …

Drug discovery for neglected diseases: molecular target-based and phenotypic approaches: miniperspectives series on phenotypic screening for antiinfective targets

IH Gilbert - Journal of medicinal chemistry, 2013 - ACS Publications
Drug discovery for neglected tropical diseases is carried out using both target-based and
phenotypic approaches. In this paper, target-based approaches are discussed, with a …

The dihydroorotate dehydrogenases: past and present

RAG Reis, FA Calil, PR Feliciano, MP Pinheiro… - Archives of biochemistry …, 2017 - Elsevier
The flavoenzyme dihydroorotate dehydrogenase catalyzes the stereoselective oxidation of
(S)-dihydroorotate to orotate in the fourth of the six conserved enzymatic reactions involved …

[HTML][HTML] MalDA, accelerating malaria drug discovery

T Yang, S Ottilie, ES Istvan, KP Godinez-Macias… - Trends in …, 2021 - cell.com
The Malaria Drug Accelerator (MalDA) is a consortium of 15 leading scientific laboratories.
The aim of MalDA is to improve and accelerate the early antimalarial drug discovery process …

Synthetic and medicinal perspective of quinolines as antiviral agents

R Kaur, K Kumar - European Journal of Medicinal Chemistry, 2021 - Elsevier
In current scenario, various heterocycles have come up exhibiting crucial role in various
medicinal agents which are valuable for mankind. Out of diverse range of heterocycle …